Cautious Hope for Cannabidiol (CBD) in Rheumatology Care.
Fitzcharles MA, Clauw DJ, Häuser W.
Arthritis Care Res (Hoboken) · research support, non-u.s. gov't; review; journal article · DOI 10.1002/acr.24176 PUBLIKATIONSREGISTRET
Gå till forskningen.
Publikationsdata från Europe PMC och PubMed. Följ källhänvisningar från ämnesregistret till originalpublikationerna.
Publikationer som ChEBI hänvisar till för cannabidiol. Visa hela publikationsregistret
En publikationsträff är inte en slutsats. Publikationslistan visar bibliografiska uppgifter. Eventuella forskningsutdrag visas separat med originalunderlag. En källhänvisning visar inte i sig effekt, dosering eller säkerhet.
Publikationer i urvalet
16 träffar[Cannabidiol (CBD): Analytical and toxicological aspects].
Alvarez JC, Pelissier AL, Mura P, Goullé JP.
Therapie · journal article; english abstract · DOI 10.1016/j.therap.2023.02.006Molecular mechanism of TRPV2 channel modulation by cannabidiol.
Pumroy RA, Samanta A, Liu Y, Hughes TE, Zhao S, Yudin Y, Rohacs T, Han S, Moiseenkova-Bell VY.
Elife · research-article; journal article; research support, n.i.h., extramural · DOI 10.7554/elife.48792The therapeutic potential of the phytocannabinoid cannabidiol for Alzheimer's disease.
Karl T, Garner B, Cheng D.
Behav Pharmacol · research support, non-u.s. gov't; review; journal article · DOI 10.1097/fbp.0000000000000247Evidences for the Anti-panic Actions of Cannabidiol.
Soares VP, Campos AC.
Curr Neuropharmacol · review-article; review; journal article · DOI 10.2174/1570159x14666160509123955The Utility of Cannabidiol in the Treatment of Refractory Epilepsy.
Reddy DS.
Clin Pharmacol Ther · review; journal article · DOI 10.1002/cpt.441Protective effect of cannabidiol on hydrogen peroxide‑induced apoptosis, inflammation and oxidative stress in nucleus pulposus cells.
Chen J, Hou C, Chen X, Wang D, Yang P, He X, Zhou J, Li H.
Mol Med Rep · journal article · DOI 10.3892/mmr.2016.5513Current Status and Prospects for Cannabidiol Preparations as New Therapeutic Agents.
Fasinu PS, Phillips S, ElSohly MA, Walker LA.
Pharmacotherapy · review; journal article · DOI 10.1002/phar.1780Does cannabidiol have a role in the treatment of schizophrenia?
Gururajan A, Malone DT.
Schizophr Res · research support, non-u.s. gov't; review; journal article · DOI 10.1016/j.schres.2016.06.022Automated GC-MS Determination of Δ9-Tetrahydrocannabinol, Cannabinol and Cannabidiol in Hair.
Heinl S, Lerch O, Erdmann F.
J Anal Toxicol · journal article · DOI 10.1093/jat/bkw047Could cannabidiol be used as an alternative to antipsychotics?
Fakhoury M.
J Psychiatr Res · research support, non-u.s. gov't; review; journal article · DOI 10.1016/j.jpsychires.2016.05.013Anti-inflammatory and antioxidant effects of a combination of cannabidiol and moringin in LPS-stimulated macrophages.
Rajan TS, Giacoppo S, Iori R, De Nicola GR, Grassi G, Pollastro F, Bramanti P, Mazzon E.
Fitoterapia · journal article · DOI 10.1016/j.fitote.2016.05.008Cannabidiol promotes browning in 3T3-L1 adipocytes.
Parray HA, Yun JW.
Mol Cell Biochem · journal article · DOI 10.1007/s11010-016-2702-5Cannabidiol and epilepsy: Rationale and therapeutic potential.
Leo A, Russo E, Elia M.
Pharmacol Res · review; journal article · DOI 10.1016/j.phrs.2016.03.005Cannabidiol, neuroprotection and neuropsychiatric disorders.
Campos AC, Fogaça MV, Sonego AB, Guimarães FS.
Pharmacol Res · review; journal article · DOI 10.1016/j.phrs.2016.01.033Cannabidiol (CBD) and its analogs: a review of their effects on inflammation.
Burstein S.
Bioorg Med Chem · review; journal article · DOI 10.1016/j.bmc.2015.01.059